Handelsavisen
prelaunch
GR
GRML Nasdaq Diversified Mining

Greenland Mines Ltd

$0,20
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
18,5M USD
P/E
EV / Rev
Div yield
Op margin
ROE
-26,9 %
Net margin
Debt / equity
Beta
52w range
Volume
Day range
$0,21–$0,24
Prev close
$0,21
Open
$0,24
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

Greenland Mines Ltd is a clinical-stage biopharmaceutical company focused on developing gene therapies for rare diseases and Alzheimer’s disease, currently operating at a significant net loss while holding a cash balance of $10.0 million.

Business. Greenland Mines Ltd (GRML) is a pharmaceutical company engaged in the development and sale of pharmaceutical products. The firm is headquartered in the United States and is primarily listed on the Nasdaq stock exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.

Classification92 %
SectorBasic Materials
Business sectorMineral Resources
IndustryDiversified Mining
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
JPMorgan Private Bank (United States)
largest disclosed fund holder
Profitability
-26,9 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning GRML.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,7 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Consumer Discretionary+0,4 %+7,7 %−0,2 %
    Information Technology+0,3 %+7,8 %−0,3 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to GRML. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    Briefing · model-assisted

    Greenland Mines Ltd (GRML) has recorded a notable addition to its shareholder base, marking a shift in ownership structure. As of December 31, 2025, investor ID 465 acquired a position of 716,547 shares, valued at approximately $0.21 million. This acquisition represents a weight of roughly 0.0003% in the investor’s portfolio, signaling a new institutional or significant private interest in the company’s equity. This development is particularly relevant given that this is the first analysis for the ticker, meaning there is no prior basis for computing delta changes in shareholder activity. The entry of a new holder into a company with only eight top holders suggests a concentrated ownership environment where individual investor moves can have a disproportionate impact on the shareholder register. The significance of this change is underscored by the company’s current profile, which shows zero analyst coverage and no index membership. In the absence of broad market scrutiny or inclusion in major indices, the addition of a new holder may reflect independent due diligence or a specific strategic interest rather than passive index-driven buying. With no other material changes or cross-source signals detected, this holder addition stands as the primary recent development for GRML. Investors should monitor whether this new position stabilizes or expands, as it could serve as an early indicator of renewed interest in the company’s underlying assets or operational prospects.

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Greenland Mines Ltd (GRML) is a pharmaceutical company engaged in the development and sale of pharmaceutical products. The firm is headquartered in the United States and is primarily listed on the Nasdaq stock exchange. Specific details regarding operating segments or geographic revenue breakdowns are not available.

    Classification92 %
    SectorBasic Materials
    Business sectorMineral Resources
    IndustryDiversified Mining
    AI synthesis
    GENERATED

    Greenland Mines Ltd maintains a debt-free capital structure with $51.5 million in total equity and $10.0 million in cash and equivalents, resulting in a current ratio of 19.74. The company’s market capitalization of $22.5 million implies a price-to-book ratio of 8.04, reflecting a premium valuation relative to its tangible book value despite negative earnings. Operating cash flow was negative $4.97 million in Q1 2026, driven by a net loss of $13.9 million, which includes non-cash items such as a $2.3 million change in warrant liability fair value and $2.0 million in impairment expenses. The company raised $7.75 million in net proceeds from the sale of securities during the quarter, partially offsetting the cash burn.

    Profitability metrics are deeply negative, with a return on equity of -26.9% and return on assets of -23.2%. The company reported an operating loss of $9.5 million in Q1 2026, a significant increase from the $1.6 million operating loss in the same period of 2025. This deterioration was primarily driven by a surge in professional fees to $2.98 million from $0.74 million and general and administrative expenses rising to $6.21 million from $0.85 million year-over-year. Research and development expenses were $0.32 million, indicating early-stage clinical or pre-clinical activity. The net loss per share was $0.15, compared to $0.08 in the prior year period.

    Greenland Mines Ltd (GRML) has recorded a notable addition to its shareholder base, marking a shift in ownership structure. As of December 31, 2025, investor ID 465 acquired a position of 716,547 shares, valued at approximately $0.21 million. This acquisition represents a weight of roughly 0.0003% in the investor’s portfolio, signaling a new institutional or significant private interest in the company’s equity. This development is particularly relevant given that this is the first analysis for the ticker, meaning there is no prior basis for computing delta changes in shareholder activity. The entry of a new holder into a company with only eight top holders suggests a concentrated ownership environment where individual investor moves can have a disproportionate impact on the shareholder register. The significance of this change is underscored by the company’s current profile, which shows zero analyst coverage and no index membership. In the absence of broad market scrutiny or inclusion in major indices, the addition of a new holder may reflect independent due diligence or a specific strategic interest rather than passive index-driven buying. With no other material changes or cross-source signals detected, this holder addition stands as the primary recent development for GRML. Investors should monitor whether this new position stabilizes or expands, as it could serve as an early indicator of renewed interest in the company’s underlying assets or operational prospects.

    Key takeaways
    • The company faces substantial doubt about its ability to continue as a going concern without additional funding.
    • Operating expenses surged to $9.5 million in Q1 2026, driven by increased professional and administrative costs.
    • Significant dilution occurred, with weighted average shares outstanding increasing from 27.5 million to 93.7 million year-over-year.
    • The company raised $7.75 million in net proceeds from securities sales, partially offsetting a $4.97 million operating cash outflow.
    • A strategic pivot is suggested by the acquisition of mineral rights and exploratory licenses, diverging from its pharmaceutical focus.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-03-31
    Q4 2025 · Quarter highlights

    Operating income -$9.5M.

    Revenue
    Operating income-$9.5M
    Net income-$13.9M
    Free cash flow
    EPS
    Operating cash flow-$5.0M
    Financials
    Income statement
    Revenue
    Gross profit
    Operating income-$9.5M
    Net income-$13.9M
    Balance sheet
    Total assets$59.7M
    Total liabilities$8.3M
    Total equity$51.5M
    Cash & equivalents$10.0M
    Long-term debt
    Cash flow
    Operating cash flow-$5.0M
    CapEx
    Free cash flow
    SBC$5.1M
    Highlights
    • Operating income -$9.5M

    Valuation FY

    Market price
    $0,20
    Market cap
    $22.5M
    Enterprise value
    $12.5M
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    8.0x
    P / Tangible book
    8.0x
    Tangible book
    $2.8M
    Net cash
    $10.0M
    Current ratio
    19.7
    Debt / equity
    ROA
    -23.2%
    ROE
    -26.9%
    Cash conversion
    36.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    -22.7%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Corporate eventM&A horizon
    M&A probabilityconf 5 %
    Probability
    5 %
    Base rate
    3 %
    Band
    180-day horizon · target 2027-01-16 · 1,8× base rate
    No acquirer candidates identified by the signal model.
    Probabilistic model output — not investment advice. · generated 2026-07-20

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskMedium
    Liquidity riskHigh
    Filing-based flags
    • Filings reference going-concern or substantial-doubt language.
    • Source documents mention dilution or offering risk.

    Benchmarks vs cohort

    ROE-26,9 %Below median
    D/E0,00Above median
    Cash Conv0,36Below median

    Corporate actions / M&A

    M&A probabilityconf —
    Probability
    5 %
    Base rate
    3 %
    Band
    Moderate
    180-day horizon · target 2027-01-16 · 1,8× base rate
    No acquirer candidates identified by the signal model.
    Corporate actionsNo corporate-action source connected yet — splits, dividends and buyback events are not tracked for this company. Honest-dim (no data fabricated).

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 90 000 sh6 grants3 insiders
    • ZENTMAN SAMUEL MDirector · Non-Qualified Stock Option → Common StockAcquired 20 000 @ $0,41grant · 2025-12-10
    • El-Dada Riad HusseinDirector · Non-Qualified Stock Option → Common StockAcquired 20 000 @ $0,41grant · 2025-12-10
    • McGarity JonDirector · Non-Qualified Stock Option → Common StockAcquired 20 000 @ $0,41grant · 2025-12-10
    • ZENTMAN SAMUEL MDirector · Non-Qualified Stock Option → Common StockAcquired 10 000 @ $0,41grant · 2025-08-07
    • El-Dada Riad HusseinDirector · Non-Qualified Stock Option → Common StockAcquired 10 000 @ $0,41grant · 2025-08-07
    • McGarity JonDirector · Non-Qualified Stock Option → Common StockAcquired 10 000 @ $0,41grant · 2025-08-07

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Regulatory filings
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    • Reference data
    How metrics are computed
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Market Cap
      market_price * shares_outstanding_diluted
    • Return On Assets
      net_income / total_assets
    • Price To Tangible Book
      market_price / (tangible_book_value / shares_outstanding_diluted)
    • Enterprise Value
      market_cap - net_cash
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • Greenland Mines Ltd company facts · 2026-07-12
    • Greenland Mines Ltd 10-Q 2026-05-20 · 2026-07-12
    • Greenland Mines Ltd 10-K 2026-04-01 · 2026-07-12
    • Greenland Mines Ltd 10-Q 2025-11-13 · 2026-07-12
    • Greenland Mines Ltd 10-Q 2025-08-18 · 2026-07-12
    • 8-K (sec_8k_material) on GRML · 2026-07-12

    Ownership & reference

    Top holders

    • JPMorgan Private Bank (United States)Investment Managers · as of 2026-03-310,01 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$0M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$0M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$0M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$0M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Insider activity

    Net buying3 buys · 1 sellsnet $285K7 insiders · last 365d
    • Sawyer Jason DavidDirector · Common StockBought 240 000 @ $0,23$56K · 2026-07-22
    • McGarity JonDirector · Common StockBought 140 000 @ $0,18$25K · 2026-07-20
    • LeBlanc JeffChief Financial Officer · Common StockBought 1 400 000 @ $0,18$245K · 2026-07-16
    • El-Dada Riad HusseinDirector · Common StockSold 175 000 @ $0,23$41K · 2026-06-25
    • LeBlanc JeffChief Financial Officer · Common StockOther 2 500 000 · 2026-03-04
    • El-Dada Riad HusseinDirector · Common StockOther 350 000 · 2026-03-04
    • ZENTMAN SAMUEL MDirector · Common StockOther 350 000 · 2026-03-04
    • Hirschman ShalomDirector · Common StockOther 350 000 · 2026-03-04
    • McGarity JonDirector · Common StockOther 350 000 · 2026-03-04
    • SINKULE JOSEPHDirector, Chief Executive Officer · Common StockOther 2 500 000 · 2026-03-04
    • SINKULE JOSEPHDirector, Chief Executive Officer · Common StockOther 400 000 · 2025-09-25
    • LeBlanc JeffChief Financial Officer · Common StockOther 200 000 · 2025-08-25
    • Hirschman ShalomDirector · Common StockOther 70 149 · 2025-08-05
    • SINKULE JOSEPHDirector, Chief Executive Officer · Common StockOther 537 180 · 2025-08-05
    • McGarity JonDirector · Common StockOther 14 641 · 2025-08-05
    • ZENTMAN SAMUEL MDirector · Common StockOther 153 494 · 2025-08-05
    • LeBlanc JeffChief Financial Officer · Common StockOther 156 199 · 2025-08-05

    Short positioning

    7.9Mshares short+23.5% vs prior
    2.11days to cover
    53.4%short of daily vol
    12.7Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    GRMLCanonical
    Nasdaq · USD

    Intel & risk

    PredictorM&A prob5 %Full forecast →
    What changed

    no material change vs prior analysis (walked 17 fields; 4 schema-expansion field(s) excluded)

    • Narrative— → —medium
    • Business summary— → —medium
    • Conclusion— → —medium
    • Key takeaways— → —medium
    vs prior analysis 2 days ago
    peak dispatch · —
    OSINT findings
    Dilution riskMedium
    Liquidity riskHigh
    Filings reference going-concern or substantial-doubt language.
    Source documents mention dilution or offering risk.

    Evidence & claims

    From filings & derived data
    • Debt-to-equity (FY 2025-12-31): 0.01xDerived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 11,159.0%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 31.2%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 31.2%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): -89.8%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 290.4%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 698.4%Derived (calculated)
    • Operating income (YoY) (2025-12-31 vs 2024-12-31): -29.0%Derived (calculated)
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -99.9%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): -71.6%Derived (calculated)
    • Return on equity (FY 2025-12-31): -111.5%Derived (calculated)
    • Return on assets (FY 2025-12-31): -110.0%Derived (calculated)
    • Current ratio (FY 2025-12-31): 95.01xDerived (calculated)
    • Total liabilities (annual): USD 129.76KSEC XBRL filing
    • Shareholders' equity (annual): USD 9.46MSEC XBRL filing
    • Current assets (annual): USD 7.29MSEC XBRL filing
    • Shares outstanding (annual): 72.54MSEC XBRL filing
    • EPS (basic) (annual): USD-PER-SHARES -0SEC XBRL filing
    • Operating income (annual): USD -7.15MSEC XBRL filing
    • R&D expense (annual): USD 634.19KSEC XBRL filing
    • Net income (annual): USD -10.55MSEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES -0SEC XBRL filing
    • Operating cash flow (annual): USD -5.89MSEC XBRL filing
    • Total assets (annual): USD 9.59MSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-07-29 22:34 UTCEVENTHa Price Listing GRML remains DEFICIENT (NASDAQ) — cure period. closed below $1.00 for 245 consecutive trading days (last close $0.2035). cure deadline 2027-01-17 (172 days remaining).
    2026-07-22INSIDERSawyer Jason David bought 240.0k sh — Director ~$56k
    2026-07-20INSIDERMcGarity Jon bought 140.0k sh — Director ~$25k
    2026-07-16INSIDERLeBlanc Jeff bought 1.40M sh — Chief Financial Officer ~$245k
    2026-07-09 04:41 UTCFILINGMaterial 8-K
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: ma_probability (180d)
    2026-06-25 00:00 UTCINSIDER1 insider transaction — 2026-06
    2026-06-25 00:00 UTCINSIDER1 insider transaction — 2026-06
    2026-06-25INSIDEREl-Dada Riad Hussein sold 175.0k sh — Director ~$41k
    2026-06-21 02:57 UTCHOLDERInstitutional holding changed
    2026-06-21 02:57 UTCHOLDER1 institutional position change flagged
    2026-06-17FILINGCURRENT REPORT →
    2026-05-26FILINGPROXY STATEMENT →
    2026-05-21FILINGCURRENT REPORT →
    2026-05-20FILINGQUARTERLY REPORT →
    2026-05-14FILINGCURRENT REPORT →
    2026-04-22FILINGCURRENT REPORT →
    2026-04-01FILINGANNUAL REPORT →
    2026-03-31EARNINGSQuarterly results — Q4 2025 Net USD -13.9M
    2026-03-23FILINGCURRENT REPORT →
    2026-03-16FILINGCURRENT REPORT →
    2026-03-12FILINGCURRENT REPORT →
    2026-03-10FILINGCURRENT REPORT →
    2026-03-04 00:00 UTCINSIDER6 insider transactions — 2026-03
    2026-03-04 00:00 UTCINSIDER6 insider transactions — 2026-03
    2026-03-04FILINGCURRENT REPORT →
    2026-03-04INSIDERMcGarity Jon transacted 350.0k sh — Director
    2026-03-04INSIDERLeBlanc Jeff transacted 2.50M sh — Chief Financial Officer
    2026-03-04INSIDEREl-Dada Riad Hussein transacted 350.0k sh — Director
    2026-03-04INSIDERZENTMAN SAMUEL M transacted 350.0k sh — Director
    2026-03-04INSIDERHirschman Shalom transacted 350.0k sh — Director
    2026-03-04INSIDERSINKULE JOSEPH transacted 2.50M sh — Director, Chief Executive Officer
    2025-12-31EARNINGSQuarterly results — Q3 2025
    2025-12-31EARNINGSAnnual results — FY 2025 Net USD -10.6M
    2025-12-10 00:00 UTCINSIDER3 insider transactions — 2025-12 3 derivative
    2025-12-10 00:00 UTCINSIDER3 insider transactions — 2025-12 3 derivative
    2025-12-10INSIDERZENTMAN SAMUEL M acquired 20.0k sh Non-Qualified Stock Option — Director
    2025-12-10INSIDEREl-Dada Riad Hussein acquired 20.0k sh Non-Qualified Stock Option — Director
    2025-12-10INSIDERMcGarity Jon acquired 20.0k sh Non-Qualified Stock Option — Director
    Showing the 40 most recent of 56 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data · Reference data Premium coverage